Insider buying last 90 days
No open-market insider purchases were filed for DD in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every DD insider filing, plotted on the chart in Gekko.Open DD in Gekko
NYSE: DD
DuPont de Nemours (DD) Stock Analysis & Forecast
Sep 28 close
$130.98−0.73 (−0.6%)
Gekko Brief
AI summaryDuPont's stock has moved this week on a string of analyst actions following its Q2 2026 results. Wells Fargo reiterated a Buy rating with a $166.00 price target, while Jefferies raised its target sharply from $59 to $177, maintaining a Buy rating after adjusted EPS rose 48% to $1.88 and revenue increased 4% to $1.819 billion year-over-year. Brokerages collectively hold a "Moderate Buy" consensus with an average 12-month target of $166.60. Separately, the City of Birmingham has filed a federal lawsuit against DuPont-related companies and other manufacturers over PFAS chemicals in firefighter gear, adding to liability concerns following a previously noted $455 million PFAS settlement.
DD closed at $130.98, down 0.6%, sitting below both its 50-day average of $136.13 and 200-day average of $137.51, with the 50-day below the 200-day. The GekkoIndex reads 60.1, placing the stock in the Accumulation zone. Price stands 6.6% above Gekko Fair Value of $122.85.
The next earnings date falls on 5 November 2026, 37 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in their respective windows. Seasonality over the next 20 trading days has averaged a 1.5% gain across 5 years, rising in 2 of them. Nine covering analysts include 7 buy and 2 hold ratings, with no sell ratings, alongside a consensus target of $170.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
DuPont de Nemours price vs fair value
Close $130.98200-day averageGekko Fair Value $122.85
DuPont de Nemours quick facts
- Market cap
- $17.68B
- P/E ratio
- 56.5
- Forward P/E
- 16.5
- EPS, TTM
- $2.33
- Revenue, TTM
- $6.99B
- Profit margin
- 0.8%
- Dividend yield
- 2.33%
- Beta
- 1.09
- Volume
- 824,626 avg 1.19M
- 1-year return
- +40.0%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±5.1%
- 50-day average
- $136.13
- 200-day average
- $137.51
- Next earnings
- Nov 5 before open
- Shares outstanding
- 135.0M
DuPont de Nemours swing-trade checklist
DuPont de Nemours scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $130.98 is below the 50-day ($136.13) and 200-day ($137.51) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
60.1, Accumulation
Reading 60.1 is in the Accumulation zone.
See the GekkoIndex - Fair valueheadwind
6.6% above
Price is 6.6% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+1.5% on average
From this point in the calendar, the next 20 trading days averaged +1.5% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
DuPont de Nemours stock chart and price history
DuPont de Nemours closed at $130.98 on Sep 28, 2026, +40.0% over the past year, inside a 52-week range of $92.46 to $157.98.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −5.6%
- 3 months
- −3.5%
- 6 months
- −3.5%
- 1 year
- +40.0%
The full DD chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DD in Gekko
Follow DuPont de Nemours through every session
Put DD on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track DD in GekkoFree for 7 days. No credit card required.
About DuPont de Nemours
DuPont de Nemours makes advanced materials and engineered solutions used across a wide range of industries. Its products touch semiconductor and circuit board manufacturing, display technology, metal finishing, safety equipment, water treatment, transportation, energy, and building materials, giving it reach into both industrial supply chains and everyday infrastructure. Customers span sectors as varied as electronics manufacturing and consumer goods, reflecting the breadth of materials science work the company carries out.
The business runs through three segments. Electronics & Industrial covers materials for chip production, circuit boards, displays including OLED components, and specialty parts such as silicone elastomers and lubricants. Mobility & Materials supplies engineering resins, silicone encapsulants, films and related products to manufacturers in transportation, renewable energy and electronics. Water & Protection focuses on systems for worker safety, water purification, transportation infrastructure, energy, medical packaging and building materials, serving customers who need engineered protective and filtration solutions.
The company operates globally, with activity across North America, Latin America, Europe, the Middle East, Africa and Asia Pacific. It is headquartered in Wilmington, Delaware, and took its current name in June 2019 after previously being known as DowDuPont Inc. Shares of DuPont de Nemours are listed on the NYSE under the ticker DD.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Chemicals: major diversified
- Website
- dupont.com
DuPont de Nemours GekkoIndex: the smart money zone
DuPont de Nemours’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.1, in the Accumulation zone, down 3 points over five sessions.
60.1Accumulation
Down 3 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 34 | +0.7% | +3.5% | ||
| Accumulation (current zone) | 152 | +0.5% | +0.2% | ||
| Neutral | 312 | +0.4% | +2.3% | ||
| Distribution | 40 | −1.3% | −3.2% | ||
| Selling | 3 | Too few readings yet | |||
Average DD share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the DD price, zone by zone.Track DD in Gekko
Is DuPont de Nemours stock overvalued? Gekko Fair Value
DuPont de Nemours trades 6.6% above Gekko Fair Value of $122.85, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what DuPont de Nemours shares are worth, recalculated every trading day.
$122.85
Gekko Fair Value, Sep 29, 2026
6.6% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open DD in Gekko
DuPont de Nemours insider and Congress trading
No open-market insider purchases were filed for DuPont de Nemours, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in DD were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for DD, plotted on the chart in Gekko.Open DD in Gekko
Buybacks
DuPont de Nemours has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $275.0M
- As a share of market cap
- 1.56%
From company filings.
Hedge funds and billionaires quarter ended Dec 31
0of the funds Gekko tracks hold DD.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
DuPont de Nemours earnings: next date and track record
DuPont de Nemours reports on Nov 5, 2026, before the open (37 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, 37 days away
- EPS estimate
- $1.89
- Revenue estimate
- $1.84B
7 of 8reports beat the EPS estimate
±4.3%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 5, 2026 AI summary
- What they said
- DuPont reported a stronger-than-expected first quarter 2026 with results that exceeded prior guidance, prompting management to raise full-year guidance. Organic sales rose 2% (4% reported), operating EBITDA improved meaningfully (operating EBITDA of $414M, +15% year-over-year reported; pro forma EBITDA +10%) and margins expanded (reported operating EBITDA margin 24.6%, +230 bps y/y; pro forma margin +130 bps). Adjusted EPS was $0.55 (+53% reported; +20% pro forma). Free cash flow generation was solid (transaction-adjusted FCF $147M; 65% conversion in Q1) and management reiterated a full-year FCF conversion target of >90%. Management announced a $275M accelerated share repurchase (ASR) under an existing $2B program and completed the Aramids divestiture (net proceeds ~ $1.1B). Key growth drivers cited include Health Care (strong organic growth, mid-to-high single digit outlook for the year), Water (mid-single digit growth full year; flat first half, up in second half driven by project timing), and strength in EV-related battery adhesives within Diversified Industrials. Management expects to cover approximately $90M of incremental cost pressures (linked to the Middle East conflict) through price increases and surcharges, with about $25M of pricing actions impacting Q2; pricing actions are mostly rolling out in May. They are progressing on margin-improvement programs (80/20 work) and stranded cost reductions on track. Management expressed confidence in operational execution and the portfolio balance but acknowledged macro and logistics headwinds tied to the Middle East situation and raw material inflation.
- Guidance
- - Company raised full-year 2026 financial guidance (no consolidated numeric shown on call). - Free cash flow conversion target >90% for full year 2026. - Company expects to absorb incremental ~$90M in cost pressures via price increases and surcharges (pricing actions largely implemented starting May; ~ $25M of price in Q2). - Water: expect mid-single digit growth for full year (flat in H1, up in H2 driven by large projects). - Health Care: expect mid-single digit growth, landing mid- to high-single digits for full year. - Margin expansion expected to continue; additional ~40 bps of margin expansion from H1 to H2 embedded in full-year guidance. - Announced $275M accelerated share repurchase under existing $2B program; completed Aramids divestiture with ~ $1.1B net proceeds.
- Risks flagged
- - Ongoing Middle East conflict and related logistics disruptions and commodity price volatility (oil, natural gas) that could escalate and negatively impact supply chains, costs, and sales. - Raw material inflation and transportation cost pressures could exceed pricing pass-through or lead to customer pushback and potential demand destruction. - Softness in construction end markets (noted weak North American residential and some packaging segments). - Execution risk if 80/20 or stranded cost actions do not deliver expected savings on timeline. - Exposure to regional disruptions around large water projects and project timing variability.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 5, 2026 | $0.55 est $0.48 | $1.68B est $1.67B | +10.3% |
| Feb 10, 2026 | $0.46 est $0.44 | $1.69B est $1.69B | +9.4% |
| Nov 6, 2025 | $1.09 est $1.14 | $3.07B est $2.90B | +0.4% |
| Aug 5, 2025 | $1.12 est $0.45 | $3.26B est $3.24B | −0.2% |
| May 2, 2025 | $1.03 est $0.96 | $3.07B est $3.04B | −1.1% |
| Feb 11, 2025 | $1.13 est $0.98 | $3.09B est $3.07B | +7.2% |
| Nov 5, 2024 | $1.18 est $1.03 | $2.86B est $3.20B | +3.0% |
| Jul 31, 2024 | $0.97 est $0.85 | $3.17B est $3.05B | +2.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
DuPont de Nemours stock forecast and analyst price targets
Analysts’ average 12-month price target for DuPont de Nemours is $170.00, +29.8% from the last close, from 9 firms rating the stock in the last 90 days.
$170.00consensus 12-month target, +29.8% from the last close
Now $130.98Avg $170.00
Low $156High $186
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Wells Fargo | $166 | +26.7% |
| Aug 10 | J.P. Morgan | $172 | +31.3% |
| Aug 9 | BMO Capital | $186 | +42.0% |
| Aug 6 | RBC Capital | $176 | +34.4% |
| Aug 6 | Morgan Stanley | $156 | +19.1% |
+0.2%average 20-day move after past Accumulation readings
+1.5%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
DuPont de Nemours seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, DuPont de Nemours averaged +1.5% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.9% | 4 of 5 |
| Next 10 trading days | +0.5% | 3 of 5 |
| Next 15 trading days | +2.0% | 3 of 5 |
| Next 20 trading days | +1.5% | 2 of 5 |
| Next 30 trading days | +12.8% | 3 of 5 |
For scale, DD’s typical 20-trading-day move in either direction is about 5.1%.
DuPont de Nemours market cap and key statistics
DuPont de Nemours’s market cap is $17.68B, with a P/E ratio of 56.5 and revenue of $6.99B over the last twelve months.
Valuation
- Market cap
- $17.68B
- P/E ratio
- 56.5
- Forward P/E
- 16.5
- EPS, TTM
- $2.33
- Gekko Fair Value
- $122.85
Trading
- Volume
- 824,626
- Avg volume, 20 days
- 1.19M
- 52-week high
- $157.98
- 52-week low
- $92.46
- Shares outstanding
- 135.0M
Financials
- Revenue, TTM
- $6.99B
- Profit margin
- 0.8%
- Return on equity
- 1.8%
- Quarterly earnings growth, YoY
- +149.6%
Risk and income
- Beta
- 1.09
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±5.1%
- Dividend yield
- 2.33%
DuPont de Nemours stock news this week
Coverage of DuPont de Nemours this week reads positive: 7 positive, 3 neutral and 3 negative headlines.
- DuPont stock gains 1.13 percent as Wells Fargo keeps targetAD HOC NEWS, Sep 28
- DuPont de Nemours, Inc. (NYSE:DD) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarketBeat, Sep 26
- DuPont de Nemours Inc. stock outperforms competitors on strong trading dayMarketWatch, Sep 25
- DuPont stock gets a USD 177 Jefferies target after Q2 growthAD HOC NEWS, Sep 25
- DuPont stock heads into the open after a 0.6 percent dropAD HOC NEWS, Sep 25
- Birmingham sues 3M, DuPont, other manufacturers over PFAS in firefighter gearWBRC, Sep 25
DuPont de Nemours peers
DuPont de Nemours’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SOLSSolstice Advanced Materials | Accumulation | 46.8% below |
| ESIElement Solutions | Neutral | 6.6% above |
| PRMPerimeter Solutions | Accumulation | 24.5% below |
| AVNTAvient | Accumulation | 32.9% below |
| NGVTIngevity | Neutral | 7.7% below |
| IOSPInnospec | Distribution | 2.1% above |
A peer links to its own page where one exists.
DuPont de Nemours stock FAQ
What is DuPont de Nemours’s market cap?
DuPont de Nemours’s market cap is $17.68B at the Sep 28, 2026 close of $130.98, with 135.0M shares outstanding. The shares trade on a P/E ratio of 56.5.
What is the DuPont de Nemours stock forecast?
The consensus analyst 12-month price target for DuPont de Nemours is $170.00, +29.8% from the last close. Of the 9 firms that rated the stock in the last 90 days, 7 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is DuPont de Nemours stock overvalued or undervalued?
On Gekko’s estimate DuPont de Nemours is overvalued: the Sep 28, 2026 close of $130.98 is 6.6% above Gekko Fair Value of $122.85. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does DuPont de Nemours report earnings next?
DuPont de Nemours is expected to report on Nov 5, 2026, before the market opens (37 days away). Analysts expect earnings of $1.89 per share on revenue of $1.84B. DuPont de Nemours beat the earnings estimate in 7 of its last 8 reports, moving 4.3% on average across the report.
What is DuPont de Nemours’s 52-week high and low?
DuPont de Nemours’s 52-week high is $157.98 and its 52-week low is $92.46; it closed at $130.98 on Sep 28, 2026, +40.0% over the past year.
Is DuPont de Nemours stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 1 as mixed (seasonality) and 2 as headwinds (trend and fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See DuPont de Nemours the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.